On the Edge of a Digital Pathology Transformation: Views from a Cellular Pathology Laboratory Focus Group.

Artificial intelligence computational pathology digital pathology image analysis whole-slide imaging

Journal

Journal of pathology informatics
ISSN: 2229-5089
Titre abrégé: J Pathol Inform
Pays: United States
ID NLM: 101528849

Informations de publication

Date de publication:
2019
Historique:
received: 14 06 2019
accepted: 08 07 2019
entrez: 4 1 2020
pubmed: 4 1 2020
medline: 4 1 2020
Statut: epublish

Résumé

Digital pathology has the potential to revolutionize the way clinical diagnoses are made while improving safety and quality. With a few notable exceptions in the UK, few National Health Service (NHS) departments have deployed digital pathology platforms. Thus, in the next few years, many departments are anticipated to undergo the transition to digital pathology. In this period of transition, capturing attitudes and experiences can elucidate issues to be addressed and foster collaboration between NHS Trusts. This study aims to qualitatively ascertain the benefits and challenges of transitioning to digital pathology from the perspectives of pathologists and biomedical scientists in a department about to undergo the transition from diagnostic reporting via traditional microscopy to digital pathology. A focus group discussion was held in the setting of a large NHS teaching hospital's cellular pathology department which was on the brink of transitioning to digital pathology. A set of open questions were developed and posed to a group of pathologists and biomedical scientists in a focus group setting. Notes of the discussion were made along with an audio recording with permission. The discussion was subsequently turned into a series of topic headings and analyzed using content analysis. Identified benefits of digital pathology included enhanced collaboration, teaching, cost savings, research, growth of specialty, multidisciplinary teams, and patient-centered care. Barriers to transitioning to digital pathology included standardization, validation, national implementation, storage and backups, training, logistical implementation, cost-effectiveness, privacy, and legality. Many benefits of digital pathology were identified, but key barriers need to be addressed in order to fully implement digital pathology on a trust and national level.

Identifiants

pubmed: 31897354
doi: 10.4103/jpi.jpi_38_19
pii: S2153-3539(22)00400-X
pmc: PMC6909548
doi:

Types de publication

Journal Article

Langues

eng

Pagination

37

Informations de copyright

Copyright: © 2019 Journal of Pathology Informatics.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Histopathology. 2018 Mar;72(4):662-671
pubmed: 28940580
JCO Clin Cancer Inform. 2019 Jun;3:1-7
pubmed: 31194585
Histopathology. 2016 Jun;68(7):1063-72
pubmed: 26409165
J Clin Pathol. 2017 Dec;70(12):1010-1018
pubmed: 28780514
J Clin Pathol. 2018 May;71(5):463-466
pubmed: 29317516
J Pathol. 2019 Oct;249(2):143-150
pubmed: 31144302
J Pathol. 2004 Dec;204(5):613-8
pubmed: 15470688
Histopathology. 2017 Jan;70(1):134-145
pubmed: 27960232
Health Technol Assess. 2004 May;8(20):iii, 1-78
pubmed: 15147611
Hum Pathol. 2008 Apr;39(4):564-72
pubmed: 18234276
Cancer Cytopathol. 2012 Apr 25;120(2):87-96
pubmed: 22367883

Auteurs

Casmir Turnquist (C)

University of Oxford Medical School, John Radcliffe Hospital, Oxford, UK.

Sharon Roberts-Gant (S)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Helen Hemsworth (H)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Kieron White (K)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Lisa Browning (L)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Gabrielle Rees (G)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Derek Roskell (D)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Clare Verrill (C)

Department of Cellular Pathology, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Nuffield Department of Surgical Sciences, Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, UK.

Classifications MeSH